122 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Infection Control Risk ... Laboratory Workup COVID ... #ICU #criticalcare ... NonIntensivist #diagnosis #management
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... #Embolism #Risk ... prognostication #diagnosis #management ... stratification #criticalcare
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... Treatment #AcutePE #Management ... #CriticalCare
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
treatments for COVID ... for potential DIs ... QT prolongation risk ... Coronavirus #Treatment #Management ... #Pharmacology #
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... CoronaVirus #Treatment #Management ... Pharmacotherapy #Pharmacology ... #CriticalCare #
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
and GI versus CV risk ... #pharmacology #comparison ... #medications #management
NSAID Selectivity Spectrum
COX-2 Selective NSAID - Celecoxib
 • Increased risk for CV events
 • Decreased risk
Celecoxib • Increased risk ... events • Decreased risk ... at increased CV risk ... selectivity #spectrum #pharmacology ... #management
COPD Exacerbations - Management
 • Identify Triggers
 • Assess Severity
 • Risk for Poor Outcomes
 •
Exacerbations - Management ... Assess Severity • Risk ... #Exacerbation #Management ... #treatment #pulmonary